Atara Biotherapeutics Inc

ATRA

Company Profile

  • Business description

    Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

  • Contact

    1280 Rancho Conejo Boulevard
    Suite 200
    Thousand OaksCA91320
    USA

    T: +1 805 623-4211

    E: [email protected]

    https://www.atarabio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    89

Stocks News & Analysis

stocks

A collection of our best stock opportunities

Our latest articles about where we see opportunities in the market.
stocks

Morningstar analyst reacts to Macquarie Group’s earnings

Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks

Undervalued ASX share showing progress in global efforts

More clarity on the path forward in the UK.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,966.703.200.04%
CAC 407,891.2490.361.16%
DAX 4024,251.50281.141.17%
Dow JONES (US)44,837.5664.36-0.14%
FTSE 1009,114.3332.890.36%
HKSE25,524.4537.68-0.15%
NASDAQ21,178.5870.270.33%
Nikkei 22540,674.55323.72-0.79%
NZX 50 Index12,936.4125.670.20%
S&P 5006,389.771.130.02%
S&P/ASX 2008,704.606.900.08%
SSE Composite Index3,609.7111.770.33%

Market Movers